CEO Dan Daviau emphasized optimism for fiscal 2026, driven by recovery in mid-market equities and continued strength in wealth management contributions. He highlighted the M&A market as one of the ...

In a report released yesterday, Andrew Hodge from Canaccord Genuity maintained a Hold rating on ARB Corporation Limited (ARBFF – Research ...

Canaccord Genuity Group Inc. ( OTCPK:CCORF) Q3 2025 Earnings Conference Call February 5, 2025 8:00 AM ET Dan Daviau – Chairman and Chief Executive Officer Nadine Ahn – Deputy Chief Financial Officer ...

Uncertainty around North American trade has hindered capital-markets activity and stalled investments in Canada, according to ...

The fundamentals for uranium appear strong, growing demand from nuclear power and AI versus limited scope for production ...

Detailed price information for Canaccord Genuity Group Inc (CF-T) from The Globe and Mail including charting and trades.

Canaccord Genuity analyst Aravinda Galappatthige maintained a Buy rating on TMX Group (TMXXF – Research Report) yesterday and set a price ...

Canaccord Genuity Group Inc. (TSE:CF – Get Free Report)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of C$9.46 and traded as ...

AxoGen (NASDAQ:AXGN – Get Free Report) had its price objective increased by investment analysts at Canaccord Genuity Group from $18.00 to $22.00 in a research report issued on Monday,Benzinga reports.

Fintel reports that on January 31, 2025, Canaccord Genuity downgraded their outlook for Intra-Cellular Therapies ...

Analysts at Canaccord Genuity lowered their target price on Ultimate Products from 182.0p to 130.0p on Monday, noting that ...